Data

Clarifying the role of phamracological factors in the pathogenesis of statin-associated muscle symptoms and the ability of geranylgeranyl pyrophosphate to prevent statin-induced muscle fatigue dataset

Central Queensland University
Jordon Irwin (Aggregated by)
Viewed: [[ro.stat.viewed]] Cited: [[ro.stat.cited]] Accessed: [[ro.stat.accessed]]
ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Adc&rfr_id=info%3Asid%2FANDS&rft_id=10018/1315313&rft.title=Clarifying the role of phamracological factors in the pathogenesis of statin-associated muscle symptoms and the ability of geranylgeranyl pyrophosphate to prevent statin-induced muscle fatigue dataset&rft.identifier=10018/1315313&rft.publisher=Central Queensland University&rft.description=This entry contains the primary datasets related to the Thesis - Clarifying the role of phamracological factors in the pathogenesis of statin-associated muscle symptoms and the ability of geranylgeranyl pyrophosphate to prevent statin-induced muscle fatigue&rft.creator=Jordon Irwin&rft.date=2019&rft_rights= https://libguides.library.cqu.edu.au/acquirelicences/general1&rft_subject=Clinical pharmacology and therapeutics&rft_subject=Statin-associated muscle symptoms (SAMS)&rft_subject=Statin-induced myotoxicity&rft_subject=Geranylgeranyl pyrophosphate (GGPP)&rft_subject=Dose&rft_subject=Clinical Pharmacology and Therapeutics&rft.type=dataset&rft.language=English Access the data
Cite Saved to MyRDA Save to MyRDA

Licence & Rights:

Other view details

Full description

This entry contains the primary datasets related to the Thesis - Clarifying the role of phamracological factors in the pathogenesis of statin-associated muscle symptoms and the ability of geranylgeranyl pyrophosphate to prevent statin-induced muscle fatigue

Issued: 04 11 2019

Data time period: 2016-03-07 to 2019-10-31

This dataset is part of a larger collection

Click to explore relationships graph
Help

Related Data

Related People

Related Grants and Projects

Subjects
Clinical Pharmacology and Therapeutics | Clinical pharmacology and therapeutics | Dose | Geranylgeranyl pyrophosphate (GGPP) | Statin-associated muscle symptoms (SAMS) | Statin-induced myotoxicity |

User Contributed Tags    

Login to tag this record with meaningful keywords to make it easier to discover

Identifiers
ACN 633 798 857